BioCentury
ARTICLE | Financial News

Tracon raises $27M in B round

September 23, 2014 3:09 AM UTC

Tracon Pharmaceuticals Inc. (San Diego, Calif.) raised $27 million in a series B round led by New Enterprise Associates. Additional new investors included BioMed Ventures and an undisclosed institutional investor. Existing investors JAFCO; Nextech Invest; Brookline Investments; Arcus Ventures; and BHP also participated.

Tracon is developing IV TRC105, a human chimeric mAb against endoglin ( CD105; ENG). The compound is in multiple oncology trials, including Phase II trials to treat renal cell carcinoma and glioblastoma and Phase I/II trials to treat metastatic breast cancer and soft tissue sarcoma. ...